NCT06292338

Brief Summary

This study aimed to determine the value of chest ultrasonography in comparison to other tools as chest x-ray and ABG in diagnosis and follow up of neonates with respiratory disorders.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2024

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 27, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 5, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

March 5, 2024

Status Verified

March 1, 2024

Enrollment Period

1 year

First QC Date

February 27, 2024

Last Update Submit

March 4, 2024

Conditions

Neonatal Respiratory Distress

Keywords

LUSNeonatesRespiratory disorders

Outcome Measures

Primary Outcomes (1)

  • Comparing between LUS and Chest xRay in neonatal respiratory disorders assessment

    Our study aimed to evaluate the relationship between the LUS score and the diagnosis of neonates hospitalized because of respiratory disorder. In our study, we also aimed to evaluate the correlation between LUS scores and blood gas parameters in patients hospitalized for respiratory distress and to get an idea about the severity of the disease.

    1 year

Eligibility Criteria

Age1 Day - 28 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

All neonates (Term and preterm) presented with respiratory disorders

You may qualify if:

  • neonates with a gestational age ≥28 weeks who are suffering from respiratory disorders.

You may not qualify if:

  • neonates having multiple congenital anomalies, chromosomal aberrations, hydrops fetalis and/or heart failure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pulmonary AtelectasisRespiration Disorders

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Specialist of pediatrics

Study Record Dates

First Submitted

February 27, 2024

First Posted

March 5, 2024

Study Start

May 1, 2024

Primary Completion

May 1, 2025

Study Completion

May 1, 2025

Last Updated

March 5, 2024

Record last verified: 2024-03